Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: genotype and clinical presentation, including impairment level (mild cognitive impairment [MCI] or dementia) and MCI type (amnestic or nonamnestic). METHODS: genotype and amyloid positivity. Analysis of covariance models assessed differences in global amyloid burden (Centiloids) across genotypes. Voxel-wise analyses examined regional tracer uptake. RESULTS: was associated with dementia and amnestic MCI. DISCUSSION: genotype to amyloid pathology in clinical settings. Limitations include restriction to cognitively impaired individuals and limited racial and ethnic diversity.
No takes yet. Share an insight, caveat, or question.
Pezzoli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: